Navigation Links
Lorus in Medical News

AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing Standards

... TORONTO, May 6 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus" or the "Company") (TSX:...y the end of the extension period. About Lorus lorus is a biopharmaceutical company focused on the rese...forts and an acquisition and in-licensing program, lorus is building a portfolio of promising anticancer dr...

Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference

...b cast- TORONTO, Nov. 6 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical c...ies for healthcare companies and investors. About lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics announces election of three new Directors and appoints a new Chairman

... TORONTO, Sept. 19 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR; AMEX: LRP), a biophar...lified individuals to our Board. They all bring to lorus an exceptional level of knowledge and experience i...g with them, to enhance shareholder value." About lorus ...
Lorus in Medical Technology

Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference

...e presented on April 17, 2007. In this research, lorus screened a series of siRNAs to select a lead drug ... development of siRNA-1284 as an anticancer agent. lorus is also pursuing other cancer targets with its siR...r drug discovery and medical therapeutics. About lorus ...
Lorus in Biological Technology

Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008

... TORONTO, July 21 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (Lorus), a biopharmaceutical com...Phase I clinical study in cancer indications. lorus intends to submit an IND for LOR-253 by the Q...srael. Under the terms of the licensing agreement, lorus is entitled to receive payments in excess of ...

Lorus Therapeutics Receives $600 Thousand From Escrow Account

... TORONTO, July 16 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a b...ce on forward-looking statements due to the inherent uncertainty therein. lorus Therapeutics Inc.'s recent press releases are available through the Company...

Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program

... TORONTO, July 9 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" o...tected in Mexico under an earlier patent issued to lorus in 2003. Virulizin(R) has demonstrated significa...locally advanced and metastatic pancreatic cancer. lorus has reported that the overall survival data in thi...

Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)

...ivity - TORONTO, July 2 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" o...te (NCI) Cancer Therapy Evaluation Program (CTEP). lorus is collaborating with the Division of Cancer Treat...r growth and metastatic potential. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions

... TORONTO, May 5 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...Lorus' senior management team. Dr. Babaei joined lorus in 2006, where he has held the progressive positio...-for-profit organizations. Dr. Lee has been with lorus for ten years, most recently serving as the Direct...

Lorus initiates development program exploring novel route of administration for LOR-2040

... TORONTO, April 22 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical c...se of LOR-2040 in the treatment of bladder cancer. lorus intends to submit the IND during Q3, 2008, followi...r growth and metastatic potential. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040

...CR) - TORONTO, April 16 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...esented on April 16, 2008. In this presentation, lorus provided data on the preclinical development of LO...nked to the development of cancer. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)

...ales - TORONTO, April 8 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...ated Asher Nathan, Managing Director of Zoticon. lorus invites analysts and media to participate in a con... Virulizin(R) is a registered trademark owned by lorus Therapeutics Inc. About...

Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer

... TORONTO, Jan. 22 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR; AMEX: LRP), a biophar...rofessional skills and integrity." About Lorus lorus is a biopharmaceutical company focused on the rese...forts and an acquisition and in-licensing program, lorus is building a portfolio of promising anticancer dr...

Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia

... TRIAL TORONTO, Aug. 29 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...fficacy evaluation in a larger patient population. lorus expects the clinical trial to be completed by the end of 2008. The decision by lorus to advance clinical development of GTI-2040 is bas...
Other Tags
(Date:8/28/2015)... ... August 28, 2015 , ... For Dallas, the time is nearing for ... subsidiary USPI Tenet Health. , The American Heart Association hosts their well-known Heart Walk ... believe that together, a difference can be made. Walkers can participate in the cause ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by Medical Daily on August ... for results that last for two years, the longest of any cellulite reduction system ... looking for a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, ... as sponsor of the “Music With A Mission” benefit concert in Mendon, IL. Held ... was to raise money to support music education programs in the underfunded local school ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint ... grade protein with zero fat, carbs, sugar, gluten, lactose or caffeine in a ... for the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, ... diagramming network and data center assets and audio-video devices, recently released Visio Stencils ... 5000 Series, HP ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3
(Date:8/17/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... The new marketing campaign is being spearheaded by an ... ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ). ... driven marketing and brand awareness and has a client ...
(Date:8/12/2015)... 12, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that four of its fingerprint ID ... officially been named FIDO Certified™ by the Fast ... certification, Synaptics, Natural ID™ fingerprint solutions are fully ... (UAF) standard and are interoperable among other products ...
(Date:8/6/2015)... CITY, Calif. , Aug. 6, 2015 /PRNewswire/ ... Valley) will visit Crossmatch ™ to learn ... networks and protect data. Crossmatch is a world ... whose technologies and expertise are helping federal agencies ... efficiency and security.   "The vast ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Rep. Honda to Visit Crossmatch in Redwood City 2
Other Contents